Publication date: Available online 23 October 2026 Source: Clinical Lung Cancer Author(s): Rupali Sood, Kevin J. Psoter, Aliyah Pabani, Cheng Ting Lin, Mohammed Ghanbar, David N. Hager, Sonye Danoff, Chad H. Hochberg, Karthik Suresh
Etiologies and Outcomes of Respiratory Failure After Immune Checkpoint Inhibitor Therapy. // Clinical Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1525730426001373?dgcid=rss_sd_all
Etiologies and Outcomes of Respiratory Failure After Immune Checkpoint Inhibitor Therapy. Clinical Lung Cancer. https://www.sciencedirect.com/science/article/pii/S1525730426001373?dgcid=rss_sd_all
“Etiologies and Outcomes of Respiratory Failure After Immune Checkpoint Inhibitor Therapy.” Clinical Lung Cancer.
@article{article40931,
title = {Etiologies and Outcomes of Respiratory Failure After Immune Checkpoint Inhibitor Therapy},
journal = {Clinical Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1525730426001373?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment